Cited by 338Angiogenesis and VEGF in CancerNitric Oxide and Endothelin EffectsMuscle Physiology and Disorders

Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism

Open access
Ouchi, Noriyuki, Oshima, Yuichi, Ohashi, Koji, Higuchi, Akiko, Ikegami, Chiaki, Izumiya, Yasuhiro, Walsh, Kenneth·2008·Journal of Biological Chemistry

Abstract

Myogenic Akt signaling coordinates blood vessel recruitment with normal tissue growth. Here, we investigated the role of Follistatin-like 1 (Fstl1) in the regulation of endothelial cell function and blood vessel growth in muscle. Transgenic Akt1 overexpression in skeletal muscle led to myofiber growth that was coupled to an increase in muscle capillary density. Myogenic Akt signaling or ischemic hind limb surgery led to the induction of Fstl1 in muscle and increased circulating levels of Fstl1. Intramuscular administration of an adenoviral vector expressing Fstl1 (Ad-Fstl1) accelerated flow recovery and increased capillary density in the ischemic hind limbs of wild-type mice, and this was associated with an increase in endothelial nitric oxide synthase (eNOS) phosphorylation at residue Ser-1179. In cultured endothelial cells, Ad-Fstl1 stimulated migration and differentiation into network structures and inhibited apoptosis under conditions of serum deprivation. These cell responses were associated with the activating phosphorylation of Akt and eNOS. Conversely, transduction with dominant-negative Akt or LY294002 blocked Fstl1-stimulated eNOS phosphorylation and inhibited Fstl1-stimulated cellular responses. Treatment with the eNOS inhibitor N(G)-nitro-L-arginine methyl ester also reduced endothelial cell migration and differentiation induced by Ad-Fstl1. The stimulatory effect of Ad-Fstl1 on ischemic limb reperfusion was abolished in mice lacking eNOS. These data indicate that Fstl1 is a secreted muscle protein or myokine that can function to promote endothelial cell function and stimulates revascularization in response to ischemic insult through its ability to activate Akt-eNOS signaling.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m803440200

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • FSTL1 has cardioprotective effects in animal models of cardiac injury, promoting endothelial cell function and revascularization through a mechanism that includes nitric oxide synthase.

    “FSTL1 has been shown to possess cardioprotective effects, promoting endothelial cell function and thereby revascularization in animal models of cardiac injury through a mechanism that includes nitric oxide synthase (194, 195).”

    From Muscle–Organ Crosstalk: The Emerging Roles of Myokines (2020) · cites this paper as [194]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Lee, R. J., Springer, M. L., Blanco-Bose, W. E., Shaw, R., Ursell, P. C., and Blau, H. M. (2000) Circulation 102, 898 -901

Cited by

Sorted by citations

Authors
Ouchi, N., Oshima, Y., Ohashi, K., Higuchi, A., Ikegami, C., Izumiya, Y., & Walsh, K.
Affiliations
Boston University (US)
Corresponding author
Ouchi, Noriyuki
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2008-11
Volume
283
Issue
47
Pages
32802-32811
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2044221698
Cited by
338
References
39
Citations by year
2026: 10 · 2025: 26 · 2024: 19 · 2023: 20 · 2022: 16 · 2021: 15 · 2020: 35 · 2019: 21 · 2018: 25 · 2017: 20 · 2016: 18 · 2015: 10 · 2014: 13 · 2013: 19 · 2012: 18
FWCI
7.12
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Heart Association
  • Uehara Memorial Foundation
  • National Institutes of Health (HL 81587, AG15052)
  • National Institute on Aging (R37AG015052, AG15052)
  • National Heart, Lung, and Blood Institute (HL81587, HL77774, R01HL086785, R01HL116591, P01HL081587, HL 86785, R01HL077774)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
FSTL1, myokines, endothelial function, revascularization, ischemia, nitric oxide synthase, Akt signaling, endothelial cell migration, endothelial differentiation, endothelial cell apoptosis, skeletal muscle, capillary density, hindlimb ischemia, reperfusion
MeSH terms
Animals, Humans, Ischemia, Male, Mice, Inbred C57BL, Models, Biological, Muscles, Phosphorylation, Nitric Oxide Synthase, Oligonucleotide Array Sequence Analysis, Follistatin-Related Proteins, Endothelial Cells, Proto-Oncogene Proteins c-akt, Mice, Nitric Oxide Synthase Type III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review